degraders
TW202641539APending Publication Date: 2026-10-16F HOFFMANN LA ROCHE & CO AG +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115101814
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-01-17
- Filing Date
- 2026-01-16
- Publication Date
- 2026-10-16
Smart Images
Figure TWG2TA001080970_001 
Figure TWG2TA001080970_002 
Figure TWG2TA001080970_003
Abstract
diabetes, ankylosing spondylitis, cutaneous lupus erythematosus, systemic lupus erythematosus, lupus nephritis, multiple sclerosis, systemic sclerosis, psoriasis, Crohn's disease, ulcerative colitis, proteasome-associated autoinflammatory syndromes (PRAAS), ISG15 deficiency, and inflammatory bowel disease; inflammatory disorders like rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, psoriasis, Crohn's disease, ulcerative colitis, STING-associated vasculopathy with onset in infancy (SAVI), and inflammatory bowel disease; proliferative disorders like hematological cancer, polycythemia vera, myelofibrosis, essential thrombocythemia, and thrombocytosis; endocrine disorders like polycystic ovary syndrome, Crouzon's syndrome, and type
Need to check novelty before this filing date? Find Prior Art